No Prescription |
 |
 | ||
|
PANTOSEC Protium |
|
| ||
No Prescription » Prescription Drugs 13 » PANTOSEC Protium Pantoprazole is used to treat gastroesophageal reflux disease (GERD) a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus). It is also used to treat conditions where the stomach produces too much acid such as Zollinger-Ellison syndrome. Pantoprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach.How should this medicine be used? Pantoprazole comes as a delayed-release (long-acting) tablet to take by mouth. It is usually taken once or twice a day with or without food. To help you remember to take pantoprazole take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take pantoprazole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow the tablets whole; do not split chew or crush them.Continue to take pantoprazole even if you feel well. Do not stop taking pantoprazole without talking to your doctor. Buy PANTOSEC Protium and other Prescription Drugs 13 products online at Medstore. 919
About PANTOSEC Protium: Product Type: Prescription Drugs 13 PANTOSEC ( Protium Protonix Generic Pantoprazole ) PANTOSEC (Protium Protonix Generic Pantoprazole) Protium Protonix Generic Pantoprazole 40mg Tabs 30 ( 3 x 10) Protium Protonix Generic Pantoprazole PANTOSEC
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
